BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36516844)

  • 21. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK; Nwoke F; Goldfarb RC; Ongseng F
    Clin Imaging; 2013; 37(3):475-9. PubMed ID: 23102932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioguided thyroidectomy for follicular tumors: Multicentric experience.
    Parmeggiani D; Gambardella C; Patrone R; Polistena A; De Falco M; Ruggiero R; Cirocchi R; Sanguinetti A; Cuccurullo V; Accardo M; Avenia N; Docimo G; Tolone S; Bassi V; Docimo L; Conzo G
    Int J Surg; 2017 May; 41 Suppl 1():S75-S81. PubMed ID: 28506419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective visualization of suppressed thyroid tissue by means of baseline 99mTc-methoxy isobutyl isonitrile in comparison with 99mTc-pertechnetate scintigraphy after TSH stimulation.
    Vattimo A; Bertelli P; Burroni L
    J Nucl Biol Med (1991); 1992; 36(4):315-8. PubMed ID: 1338363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.
    Saggiorato E; Angusti T; Rosas R; Martinese M; Finessi M; Arecco F; Trevisiol E; Bergero N; Puligheddu B; Volante M; Podio V; Papotti M; Orlandi F
    J Nucl Med; 2009 Nov; 50(11):1785-93. PubMed ID: 19837765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
    Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
    Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the neoplastic potential of solitary solid thyroid lesions with Tc-99m-pertechnetate and Tc-99m-sestamibi scanning.
    Wei JP; Burke GJ
    Ann Surg Oncol; 1995 May; 2(3):233-7. PubMed ID: 7641020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT.
    Shih WJ; Stipp V; Magoun S; Ain KB; Pulmano C
    Clin Nucl Med; 1996 Mar; 21(3):213-7. PubMed ID: 8846566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of F-18 FDG-PET/CT and Tc-99m MIBI in the preoperative evaluation of cold thyroid nodules in the same patient group.
    Sager S; Vatankulu B; Erdogan E; Mut S; Teksoz S; Ozturk T; Sonmezoglu K; Kanmaz B
    Endocrine; 2015 Sep; 50(1):138-45. PubMed ID: 25795290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TC99m MIBI scintigraphy in well-differentiated thyroid carcinoma.
    Sehgal AK; Sathekge MM; Mageza RB; Modiba MC
    Cent Afr J Med; 2001 Apr; 47(4):97-102. PubMed ID: 11921678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High retention of (99m)Tc-MIBI in delayed phase as a pitfall in the combined parathyroid-thyroid scintigraphy].
    Verdú J; Lizárraga C; Clavel J; Prata I; Calbo J; Pomares F
    Rev Esp Med Nucl; 2010; 29(5):251-3. PubMed ID: 20381207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [99mTc]MIBI scintigraphy in a patient with thyroid follicular neoplasm: a case report and review of literature.
    Arabi M; Zamani H; Soltanabadi M; Kalhor L
    Nucl Med Rev Cent East Eur; 2021; 24(2):118-119. PubMed ID: 34382681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative scintigraphic detection of cervical metastases from thyroid carcinoma with technetium-99m pertechnetate.
    Vieras F
    Clin Nucl Med; 1985 Aug; 10(8):567-9. PubMed ID: 2994934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
    Oki GC; Zantut-Wittmann DE; de Oliveira Santos A; Guariento MH; Tambascia MA; de Almeida EA; Amorim BJ; Lima MC; Etchebehere EC; Camargo EE; Ramos CD
    Clin Nucl Med; 2010 Apr; 35(4):223-7. PubMed ID: 20305407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioisotope imaging for the evaluation of thyroid neoplasia and hypothyroidism in a dog.
    Branam JE; Leighton RL; Hornof WJ
    J Am Vet Med Assoc; 1982 May; 180(9):1077-9. PubMed ID: 6282795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign cervical thymoma masquerading as a malignant thyroid nodule.
    Lanka KP; Sarin B; Prasad V; Sen S; Mehta A; Rawat HS; Mondal A; Sharma R
    Clin Nucl Med; 2002 Dec; 27(12):862-4. PubMed ID: 12607863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of technetium-99m MIBI and thallium-201 retention in solitary cold thyroid nodules with postoperative histopathology.
    Erdil TY; Ozker K; Kabasakal L; Kanmaz B; Sönmezoglu K; Atasoy KC; Turoglu HT; Uslu I; Isitman AT; Onsel C
    Eur J Nucl Med; 2000 Jun; 27(6):713-20. PubMed ID: 10901459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
    Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.